<DOC>
	<DOCNO>NCT00349180</DOCNO>
	<brief_summary>This study perform confirm optimal dose THR ( total hip replacement ) .</brief_summary>
	<brief_title>Total Hip Replacement Study With XRP4563 ( Enoxaparin Sodium )</brief_title>
	<detailed_description />
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>Patients undergo elective primary THR ( total hip replacement ) surgery Patient risk clinical significant bleeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Total Hip Replacement</keyword>
	<keyword>Enoxaparin</keyword>
</DOC>